← Open Payments lookup

CYNTHIA GUZMAN: Open Payments

NPI 1083355242 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,904 in 144 payments from 18 companies in 2025. Trend: 2023 $3,439 · 2024 $3,991 · 2025 $3,904

Food & beverage: $3,805Education: $99
CompanyPaymentsAmount
ABBVIE INC.35$774
Madrigal Pharmaceuticals11$650
Janssen Biotech, Inc.22$466
Lilly USA, LLC11$415
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$319
Phathom Pharmaceuticals, Inc.6$299
Takeda Pharmaceuticals U.S.A., Inc.6$209
Ardelyx, Inc.10$182
PFIZER INC.10$181
Celltrion USA Inc.5$113

Products named: REZDIFFRA, TREMFYA, OMVOH, LINZESS, XIFAXAN, VOQUEZNA, IBSRELA, CREON.

Industry payments across TX — which companies pay providers there.